Richard Holub
Neurology · Albany, NYNPI 1497701635
Payments from drug & device makers
Across 650 payments — averaging $9726.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$2.1M
- Eli Lilly$2M
- Janssen Research & Development, LLC$1.1M
- Biogen$586K
- E.r. Squibb & Sons, L.L.C.$315K
- Acadia Pharmaceuticals Inc$92K
- plus $122K from 21 others
Across 7 payments — averaging $1842.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$13K
What the payments were for
- Consulting fees$4,23534%
- Speaking & faculty fees$210%
- Travel & lodging$4,73438%
- Food & beverage$3,51028%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 443 | $2,054,177 |
| Eli Lilly | 23 | $2,043,884 |
| Janssen Research & Development, LLC | 51 | $1,110,463 |
| Biogen | 10 | $585,702 |
| E.r. Squibb & Sons, L.L.C. | 13 | $314,681 |
| Acadia Pharmaceuticals Inc | 21 | $91,532 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $88,428 |
| AbbVie | 2 | $12,549 |
| Genentech, Inc. | 4 | $11,813 |
| Novartis | 27 | $6,911 |
| Merck | 9 | $1,459 |
| UCB, Inc. | 6 | $118 |
| Sunovion Pharmaceuticals Inc. | 5 | $98 |
| Sanofi | 5 | $95 |
| Avanir Pharmaceuticals, Inc. | 5 | $78 |
| Acorda Therapeutics, Inc | 4 | $66 |
| Adamas Pharmaceuticals, Inc. | 4 | $62 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $24 |
| Bristol Myers Squibb | 1 | $24 |
| Amneal Pharmaceuticals LLC | 2 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Livanova USA, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,322,347 in reported general payments places this provider in the 95th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Galantamine ErGalantamine Hbr | 27 | $4,249 |
| Donepezil Hcl | 85 | $853 |
| Quetiapine Fumarate | 20 | $203 |
| Escitalopram Oxalate | 26 | $48 |
Paid to pharmacies, not to this prescriber.
Other neurology in Albany
- Krupa PandeyAlbany$3.8M
- Charles ArgoffAlbany$1.7M
- David HartAlbany$1.7M
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.